Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 529 results found. Search for [ covid-19 human trials ]

Results 40 to 60 of 529
BusinessToday.In
February 2, 2021
Mahindra shared a snippet of information which claimed that a small biotech firm in West Sussex, England is working on putting a COVID-19 vaccine into a simple pill


Reuters
January 30, 2021
The review, of more than 40 publicly available documents and research papers in Chinese and English, shows BGI's links to the People's Liberation Army (PLA) include research with China's top military supercomputing experts


BusinessToday.In
January 30, 2021
Sputnik V is undergoing Phase-3 trials in India currently which is expected to be completed by February


PTI
January 22, 2021
There were no serious side effects in the participants enrolled for the phase 1 trial of Covaxin, according to the results published in The Lancet


PTI
January 18, 2021
Tata Steel, ArcelorMittal Nippon Steel India and Rashtriya Ispat Nigam Ltd said they will continue to support the government in the nationwide drive and will wait till vaccines are available for corporates


PTI
January 15, 2021
With eight different coronavirus spike fragments, the scientists said this vaccine platform can generate a diverse antibody response -- an advantage over traditional vaccine methods that present pieces from only a single type of virus


Joe C Mathew
January 13, 2021
The pre-prints or preliminary reports of research work related to Covaxin, which are yet to be peer-reviewed are already posted on pre-print servers like bioRxiv, medRxiv and Research Square


BusinessToday.In
January 8, 2021
Bharat Biotech chairman Krishna Ella says this nasal vaccine will revolutionise Indian vaccine making capabilities and help it leapfrog along with Europe, the US and China


Hemender Sharma
January 5, 2021
Bhopal gas activist Rachna Dhingra through a tweet on Sunday had alleged that poor and vulnerable residents of gas affected communities were herded by the People's University with a promise of Rs 750


BusinessToday.In
January 5, 2021
Talking to BusinessToday.In, Dr. Krishna Ella, Chairman and MD, Bharat Biotech, said the trial would take around four months and if the regulator gives quick permission the company might start with the clinical trial


Manoj Sharma
January 5, 2021
There was immense pressure on governments to develop a vaccine at the earliest due to the destruction COVID-19 pandemic was unleashing. This led to a race among pharma companies to be the first to develop a vaccine


Reuters
January 4, 2021
Scientists say the new South African variant has multiple mutations in the important \"spike\" protein that the virus uses to infect human cells


BusinessToday.In
January 4, 2021
Bharat Biotech's Chairman and Managing Director Dr. Krishna Ella, in a press conference on Monday, January 5, clarified that its vaccine is safe and the company is conducting trials in over 12 countries besides India


BusinessToday.In
January 4, 2021
Defending Covaxin, the Bhart Biotech Chairman said that his company has tremendous experience in developing vaccines; more than 70 articles on data related to Covaxin have been published in various journals


BusinessToday.In
January 3, 2021
COVID-19 vaccines in India: Oxford-AstraZeneca's coronavirus vaccine Covishield and Bharat Biotech's COVID vaccine Covaxin will be India's first vaccines


BusinessToday.In
January 3, 2021
Coronavirus vaccine trials: Bharat Biotech said that it is steadily moving towards its goal of 26,000 volunteers. Phase 3 of human clinical trials for Covaxin began in mid-November


BusinessToday.In
January 2, 2021
The SEC has recommended Covaxin for emergency use authorisation; the recommendation, along with rollout modalities, will now be taken up by the DCGI for a final decision on the matter


Reuters
December 29, 2020
A Chinese court handed down a four-year jail term on Monday to Zhang Zhan, who reported at the peak of the crisis in the city where the coronavirus first emerged


PTI
December 27, 2020
Dalal Street witnessed gut-churning fluctuations, with the BSE Sensex swinging between historic losses and eye-popping gains, sometimes in the same session


BusinessToday.In
December 25, 2020
COVAXIN also stated that promising results in the phase 1 and phase 2 trials of the Bharat Biotech COVID-19 vaccine have led to the phase 3 trials


PAGES 3 OF 27  12345